/
Login
Analysis Scores
Lothien Robustness Score?
66/100
Strong
The factor score and time-horizon weights were measured only on the past data of companies that trade today; companies that left the exchange in the past are not part of this measurement.
Neden bu skor?
Damodaran ?
52/100
Dalio Risk ?
67/100
Piotroski ?
4/9
Neutral
Previous period ROA data missing (C1 delta-ROA); Previous year data missing → margin comparison unavailable (C8)
Graham ?
NT$115.2
Pahalı
Active Metric?
4/4
Confidence?
75%
Lothien Robustness Summary
78/100
Lothien Sağlamlık: Çok Güçlü (78/100)
Temel göstergelerin büyük çoğunluğu pozitif. Kârlılık, büyüme ve değerleme açısından güçlü görünüm. | Kısa Vade: Olumlu | Uzun Vade: Olumlu | Pozitif: 7 | Negatif: 2 | Nötr: 1
Net Kâr Pozitif
Son çeyrekte NT$653M net kâr açıklandı. Şirket kârlı.
Çeyreklik Kâr Artışı
Net kâr bir önceki çeyreğe göre %+210.1 arttı (NT$211M → NT$653M). Kısa vadede olumlu momentum.
Yıllık Kâr Büyümesi Güçlü
Geçen yılın aynı dönemine göre net kâr %+30.6 arttı. Büyüme trendi sağlıklı.
3 Çeyrek Üst Üste Artış
Son 3 çeyrek üst üste kâr artıyor. Güçlü yukarı trend devam ediyor.
Hasılat Büyümesi Güçlü
Satış gelirleri çeyreklik %+142.2 arttı (NT$1.8B → NT$4.3B). Talep güçlü.
Yüksek Net Kâr Marjı
Net kâr marjı %15.2. Her 100NT$ satıştan 15NT$ kâr kalıyor.
Borç Hızla Artıyor
Toplam borç çeyreklik %+33.5 arttı. Finansman maliyetleri yükselir.
Kârlı ama Nakit Üretemiyor
Net kâr pozitif (NT$653M) ama FCF negatif (-NT$953M). Yatırım harcamaları yüksek veya alacak birikimi var.
FAVÖK Büyümesi
FAVÖK çeyreklik %+159.0 arttı (NT$373M → NT$967M). Operasyonel verimlilik artıyor.
Makul F/K
Trailing F/K: 11.1. Makul değerleme aralığında.
Data date 2026-10-22 Not investment advice; the figures are rule-based model output. How the scores are computed
Score record
Method
How the scores are computed
· Scorecard
Data date
2026-10-22
Update frequency
Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run
Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.
AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.
Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.
WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.
Model output; not investment advice; different models can disagree. Report an error
Risk Analysis (VaR)
Yüksek
229 days
Annual Volatility ?
%46.4
VaR 95% ?
%4.96
daily max loss
VaR 99% ?
%6.95
daily max loss
CVaR 95% ?
%6.09
expected loss (tail)
Max Drawdown ?
%41.5
17.11.2025 → 02.06.2026
Skewness ?
-1.30
Parametrik%4.96
Historik%3.42
Cornish-Fisher%5.00
Return Distribution
Valuation
Potential?
+22.6%
ROIC ?
12.9%
DCF Value ?
169.64
Debt Cycle?
Early Expansion
Balance Sheet Analysis?
Q2026/6
Net kâr çeyreklik %+210.1 artarak 653.4M TWD oldu
Yıllık net kâr büyümesi %+30.6
Hasılat çeyreklik %+142.2 büyüdü (4.3B TWD)
Yıllık hasılat büyümesi güçlü (%+33.9)
Brüt kâr marjı: %22.3
Brüt marj değişimi: %+2.5 puan
Net kâr marjı yüksek: %15.2
FAVÖK çeyreklik %+159.0 büyüdü (967.3M TWD)
FAVÖK marjı: %22.5
Toplam borç %+33.5 arttı → 4.4B TWD
Net borç: 3.6B TWD
Borç/Özkaynak oranı düşük: 0.46x
Cari oran < 1: 0.85x — likidite riski
Nakit %+18.9 arttı → 826.6M TWD
İşletme nakit akışı pozitif: 565.1M TWD
Serbest nakit akışı negatif: -953.1M TWD — yatırımlar nakdi aşıyor
ROE düşük: %6.7
ROA: %3.4
Toplam varlıklar %+15.5 büyüdü → 19.2B TWD
Özkaynak: 9.7B TWD (%-3.3)
İşletme kârı pozitif: 857.1M TWD
İşletme kârı büyüme: %+205.9
Faiz karşılama oranı güçlü: 78.7x (Faiz: 12.3M TWD)
Ödenmiş sermaye: 176.0M TWD
Net işletme sermayesi negatif: -778.5M TWD — kısa vadeli baskı
İşletme sermayesi değişimi: %-26.6
Yoğun yatırım dönemi: CAPEX/Hasılat %35.4 (1.5B TWD)
Son 6 çeyrek ardışık kâr
Fiyat TRAMA-99 altında: %-13.5 — teknik trend olumsuz
Direnç seviyesi: TRAMA-99 = 137.02 TWD
Fundamental & Technical Analysis
Profitability
Net Profit Margin
%15.2
Net profit margin %15.2 — at healthy level. Compared to previous quarter +3.3 point increase.
ROE - Return on Equity (TTM)
%19.0
ROE %19.0 — moderate return on equity.
EBITDA Margin
%22.5
EBITDA margin %22.5 — good operational performance.
Gross Profit Margin
%22.3
Gross profit per revenue %22.3. Evaluate relative to sector.
Free Cash Flow Margin (TTM)
%-42.7
TTM Free Cash Flow is %-42.7'i. Negative FCF — company consuming cash.
Valuation
P/E Ratio
11.1x
Sector: 15.1x
F/K 11.1x — sector median (15.1x) near reasonable levels.
P/B Ratio
2.14x
Sector: 2.21x
PD/DD 2.14x — sector median (2.21x) below or near. Reasonable valuation.
EV/EBITDA
8.8x
Sector: 10.7x
EV/EBITDA 8.8x — sector median (10.7x) in line.
Indebtedness
Current Ratio
0.85x
Current ratio 0.85x — short-term liabilities exceed current assets. Liquidity risk.
Net Debt / EBITDA
1.6x
Net Debt/EBITDA 1.6x — manageable debt level.
Debt / Equity
0.46x
Low leverage — majority of assets financed by equity.
Interest Coverage
60.9x
Interest coverage 60.9x — very wide margin for paying interest expenses.
Growth
Revenue Growth (YoY)
%+33.9
Revenue YoY %33.9 grew (2026/6) — strong growth. Sector expansion and/or market share increase.
Net Profit Growth (YoY)
%+30.6
Net profit YoY %30.6 increased — strong profit growth.
Score Explanations
Lothien Robustness
66/100
Good robustness (66/100). The company shows a generally balanced financial profile; some areas have room for improvement.
Strong
Potential
+22.6%
Plus %22.6 expected value (145.34) vs current price comparison. 4/4 valuation models could be calculated. Model confidence %75.
Components: PE target: 166.29 | P/B target: 131.51 | EV/EBITDA target: 144.02 | DCF target: 169.64
Damodaran Valuation
52/100
Moderate Damodaran score (52/100). ROIC (%12.9) – WACC (%10.6) difference +2.4 bps. Value creation capacity limited.
Moderate
Dalio Risk Analysis
67/100
Moderate debt risk (67/100). Interest coverage ratio 60.9x — strong. Debt/EBITDA 1.6x — in healthy range.
Leverage: 87/100 | Debt Service: 71/100 | Quality: 89/100
ROIC - Return on Capital
%12.9
ROIC (%12.9) slightly exceeds cost of capital (2.4 points).
WACC: %10.6
DCF Discounted Cash Flow
169.64
DCF modeli 169.64 target value produced — compared to current price %43.2 undervalued.
Current price: 118.50
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
4/9
Weak Piotroski (4/9). Many balance sheet quality criteria not met. Note: Previous period ROA data missing (C1 delta-ROA); Previous year data missing → margin comparison unavailable (C8)
Neutral
Graham Intrinsic Value
NT$115.2
Expensive
⚖️ Sector Comparison
P/E Ratio
11.1x
vs 15.1x
Sector median's %27 below — cheap
P/B Ratio
2.14x
vs 2.21x
Compared to sector %3 cheaper (by book value)
EV/EBITDA
8.8x
vs 10.7x
Compared to sector %18 lower EV/EBITDA
ROIC vs WACC
%12.9
vs %10.6 WACC
ROIC 2.4 bps above cost of capital
Net Profit Margin (TTM)
%15.4
vs %22.9 EBITDA margin
TTM net profit margin %15.4
TRAMA-99 Trend — Downtrend
Price (118.50), TRAMA-99 line's %13.5 below. Downtrend ongoing — technical outlook negative. Pressure may continue until TRAMA is broken above.
Price:: 118.50
TRAMA: 137.02
Difference: %-13.5
Charts
Indicators
BB deviation
?
RSI thresholds
?
7786 — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.